Literature DB >> 31899550

Multiorgan involvement and management in children with Down syndrome.

Niamh Lagan1,2, Dean Huggard1, Fiona Mc Grane1,2, Timothy Ronan Leahy3, Orla Franklin4, Edna Roche1,5, David Webb1,6, Aengus O' Marcaigh7, Des Cox8, Afif El-Khuffash9, Peter Greally1,10, Joanne Balfe1,2, Eleanor J Molloy1,2,11.   

Abstract

AIM: To review multiorgan involvement and management in children with Down syndrome (DS).
METHODS: A literature review of articles from 1980 to 2019 using the MEDLINE interface of PubMed was performed using the following search terms- [Down syndrome] or [Trisomy 21] AND [Cardiology] or [Respiratory] or [neurodevelopment] or [epilepsy] or [musculoskeletal] or [immune system] or [haematological] or [endocrine] or [gastrointestinal] or [ophthalmological] or [Ear Nose Throat] or [dermatology] or [renal].
RESULTS: Congenital heart disease particularly septal defects occur in over 60% of infants with DS and 5%-34% of infants develop persistent pulmonary hypertension of the newborn irrespective of a diagnosis of congenital heart disease. Early recognition and management of aspiration, obstructive sleep apnoea and recurrent lower respiratory tract infections (LRTI) could reduce risk of developing pulmonary hypertension in later childhood. Children with DS have an increased risk of autistic spectrum disorder, attention deficit disorder and epilepsy particularly infantile spasms, which are associated with poor neurodevelopmental outcomes. Congenital anomalies of the gastrointestinal and renal system as well as autoimmune diseases, coeliac disease, arthropathy, thyroid dysfunction fold diabetes mellitus and dermatological conditions are more common. Hearing and visual anomalies are also well recognised association with DS (Table 1).
CONCLUSION: Children with DS are at an increased risk of multiorgan comorbidities. Organ-specific health surveillance may provide holistic care for the children and families with DS throughout childhood.
© 2020 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Trisomy 21; down syndrome; health surveillance guidelines; multiorgan Involvement; screening

Mesh:

Year:  2020        PMID: 31899550     DOI: 10.1111/apa.15153

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

Review 1.  Neurologic complications of Down syndrome: a systematic review.

Authors:  Jonathan D Santoro; Dania Pagarkar; Duong T Chu; Mattia Rosso; Kelli C Paulsen; Pat Levitt; Michael S Rafii
Journal:  J Neurol       Date:  2020-09-12       Impact factor: 6.682

Review 2.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

3.  Endocrinal dysfunction in children with Down syndrome.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-03-31

4.  Overexpression of the Hsa21 Transcription Factor RUNX1 Modulates the Extracellular Matrix in Trisomy 21 Cells.

Authors:  Nunzia Mollo; Miriam Aurilia; Roberta Scognamiglio; Lucrezia Zerillo; Rita Cicatiello; Ferdinando Bonfiglio; Pasqualina Pagano; Simona Paladino; Anna Conti; Lucio Nitsch; Antonella Izzo
Journal:  Front Genet       Date:  2022-03-10       Impact factor: 4.599

5.  Response to treatment and outcomes of infantile spasms in Down syndrome.

Authors:  Susan Harvey; Nicholas M Allen; Mary D King; Bryan Lynch; Sally A Lynch; Mary O'Regan; Declan O'Rourke; Amre Shahwan; David Webb; Kathleen M Gorman
Journal:  Dev Med Child Neurol       Date:  2022-01-29       Impact factor: 4.864

6.  Immune screening in children with Down Syndrome.

Authors:  Dean Huggard; Amy P Worrall; Colin Kirkham; Fiona McGrane; Rajan Mandira; Laura Casey; Therese Condon; Sara George; Niamh Lagan; Edna Roche; Joanne Balfe; Timonthy Ronan Leahy; Eleanor J Molloy
Journal:  Acta Paediatr       Date:  2022-07-24       Impact factor: 4.056

Review 7.  Perioperative care of adults with Down syndrome: a narrative review.

Authors:  Elizabeth B Malinzak
Journal:  Can J Anaesth       Date:  2021-06-24       Impact factor: 6.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.